BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11811968)

  • 1. Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti-pRB monoclonal antibodies.
    Suzuki S; Tamai K; Yoshida S
    Anal Biochem; 2002 Feb; 301(1):65-74. PubMed ID: 11811968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.
    Zarkowska T; U S; Harlow E; Mittnacht S
    Oncogene; 1997 Jan; 14(2):249-54. PubMed ID: 9010227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
    J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-type cyclins and G1 progression during liver development in the rat.
    Boylan JM; Gruppuso PA
    Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites.
    Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR
    Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation.
    Juan G; Gruenwald S; Darzynkiewicz Z
    Exp Cell Res; 1998 Feb; 239(1):104-10. PubMed ID: 9511729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
    Yoshida J; Ishibashi T; Nishio M
    Biochem Pharmacol; 2007 Apr; 73(7):943-53. PubMed ID: 17217918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression.
    Boylan JF; Sharp DM; Leffet L; Bowers A; Pan W
    Exp Cell Res; 1999 Apr; 248(1):110-4. PubMed ID: 10094818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.
    Adams PD; Li X; Sellers WR; Baker KB; Leng X; Harper JW; Taya Y; Kaelin WG
    Mol Cell Biol; 1999 Feb; 19(2):1068-80. PubMed ID: 9891042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
    Kõivomägi M
    Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.